Dr Margherita GianniniRhumatologue à Strasbourg

2026Clinical and experimental rheumatologyPubMed

Comment on: Mitochondrial abnormalities in idiopathic inflammatory myopathies by Torri et al.: a short reader guide

2025Annals of the rheumatic diseasesPubMed

Enhanced proteasome activity in perifascicular myofibres is a hallmark of dermatomyositis and its inhibition is efficient in preclinical models

2025Rheumatology (Oxford, England)PubMed

Aquaporin-4 downregulation in dysphagic patients with idiopathic inflammatory myopathies: myofiber vulnerability and inflammation drivers

2025Arthritis research & therapyPubMed

Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive study

2025Medecine sciences : M/SPubMed

[Increased circulating level of fatty acid-binding protein 3 (FABP3): a potential biomarker of muscle damage in inflammatory myopathies patients]

2025Annals of the rheumatic diseasesPubMed

Response to: 'Lipid droplets at center stage in IMNM? - An ultrastructural 2D large scale quantification' by Focks et al. New insights into pathology, serology, and pathophysiology highlight IMNM as a heterogeneous group of inflammatory myopathies

2025Annals of the rheumatic diseasesPubMed

The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project

2025RMD openPubMed

Experimental myositis: an optimised version of C-protein-induced myositis

2025Clinical and experimental rheumatologyPubMed

The classification of myositis: setting the stage for a universal terminology

2024Rheumatology (Oxford, England)PubMed

Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies

2024Nature communicationsPubMed

IFNγ causes mitochondrial dysfunction and oxidative stress in myositis

2024Nature reviews. RheumatologyPubMed

Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups

2024Clinical and experimental rheumatologyPubMed

Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort

2024Clinical and experimental rheumatologyPubMed

Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis

2024Rheumatology (Oxford, England)PubMed

Comment on: Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study

2023Arthritis & rheumatology (Hoboken, N.J.)PubMed

Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria

2023RMD openPubMed

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study

2022Frontiers in immunologyPubMed

Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis

2022Acta neuropathologica communicationsPubMed

Inclusion body myositis and Sjögren's syndrome: the association works both ways

2022Rheumatology (Oxford, England)PubMed

Comment on: Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS: Reply

2022Rheumatology (Oxford, England)PubMed

Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients

2021Rheumatology (Oxford, England)PubMed

Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis

2021Rheumatology (Oxford, England)PubMed

Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis

2021Rheumatology (Oxford, England)PubMed

Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS

2020Clinical and experimental rheumatologyPubMed

Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis

2019Journal of clinical medicinePubMed

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

2026Current opinion in rheumatologyPubMed

Uncovering scleromyositis: no myth, just missed

2025International journal of molecular sciencesPubMed

Impaired Peripheral Blood Mononuclear Cell (PBMC) Mitochondrial Respiration Is Associated with Mortality and Long COVID Syndrome Severity in COVID-19 Patients

2025Annals of the rheumatic diseasesPubMed

In immune-mediated necrotising myopathy, anti-HMGCR antibodies inhibit HMGCR activity, leading to the sarcoplasmic accumulation of lipid droplets and myofibres necrosis

2024Clinical and experimental rheumatologyPubMed

Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

2022Acta neuropathologica communicationsPubMed

Inclusion body myositis and Sjögren's syndrome: the association works both ways

2022Rheumatology (Oxford, England)PubMed

Comment on: Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS: Reply

2022Rheumatology (Oxford, England)PubMed

Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients

2021Rheumatology (Oxford, England)PubMed

Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS

2026Annals of the rheumatic diseasesPubMed

Spatial transcriptomics reveals mechanism of autoimmunity driven by internalised autoantibodies

2026medRxiv : the preprint server for health sciencesPubMed

Spatial transcriptomics reveals mechanism of autoimmunity driven by internalized autoantibodies

2026NutrientsPubMed

Prevalence and Clinical Correlates of Sarcopenia and Malnutrition in Lung Transplant Recipients Using EWGSOP2 and GLIM Criteria

2021Arthritis research & therapyPubMed

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

2026Muscles (Basel, Switzerland)PubMed

Phosphodiesterase 4 (PDE 4) Inhibition Reduces Ischemia-Reperfusion-Induced Leucocyte Infiltration, Apoptosis and Mitochondrial Fission Markers in Mice Skeletal Muscles Four Hours After Ischemia Onset

2021Rheumatology (Oxford, England)PubMed

Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis

2020Journal of cachexia, sarcopenia and musclePubMed

Sarcopenia and peripheral arterial disease: a systematic review

2017Autoimmunity reviewsPubMed

Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study

2022Frontiers in immunologyPubMed

Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis

2021Autoimmunity reviewsPubMed

Histopathological features of systemic sclerosis-associated myopathy: A scoping review

2020Journal of cachexia, sarcopenia and musclePubMed

Sarcopenia and peripheral arterial disease: a systematic review

2023 · Strasbourg

Myopathies inflammatoires : mécanisme de l'effet thérapeutique des glucocorticoïdes, caractérisation des dégâts musculaires, nouveaux sous-types émergents